Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_assertion type Assertion NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_head.
- NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_assertion description "[Genetic polymorphisms in genes related to metabolism and action sites of gemcitabine showed associations with the therapeutic efficacy, in terms of OS, TTP and disease progression in pancreatic cancer patients treated with gemcitabine-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_provenance.
- NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_assertion evidence source_evidence_literature NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_provenance.
- NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_assertion SIO_000772 22838950 NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_provenance.
- NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_assertion wasDerivedFrom befree-20140225 NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_provenance.
- NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_assertion wasGeneratedBy ECO_0000203 NP300538.RAn20IjWF5uZfLFap39-IuID6_vF44gTShJa8yr5Scz7o130_provenance.